Ute Klarmann-Schulz

ORCID, self-asserted

ORCID 0000-0001-5826-0196

Publications

Citations

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

16 works in the graph, newest first.

Establishing a filarial clinical research platform in a resource-limited setting: Lessons and experiences from Tanzania
2026PLoS neglected tropical diseasesJournalOpen access1 citations10.1371/journal.pntd.0013983
Helminth Antigens Modulate Virus-Induced Activation of CD154 (CD40L) Expression on T Cells in Onchocerca volvulus-Infected Individuals
2026PathogensJournalOpen access0 citations10.3390/pathogens15010093
Comparison of six weeks doxycycline versus six weeks rifampicin or three weeks of the combination of doxycycline plus rifampicin in the treatment of onchocerciasis: a randomized, placebo-controlled, double-blind, phase 2 trial
2026Open Forum Infectious DiseasesJournalOpen accessCorresponding0 citations10.1093/ofid/ofag065
Assessing the efficacy of high-dose rifampicin plus albendazole against onchocerciasis
2026PLoS neglected tropical diseasesJournalOpen access0 citations10.1371/journal.pntd.0014594
Robust COVID-19 Vaccine Responses Despite Filarial Co-Infection: Insights from a Lymphatic Filariasis Cohort in Ghana
2025VaccinesJournalOpen access4 citations10.3390/vaccines13030312
Helminth Seropositivity Inversely Correlated with Th1 and Th17 Cytokines and Severe COVID-19
2025VaccinesJournalOpen access3 citations10.3390/vaccines13030252
Changes in circulating filarial antigen status in previously positive individuals: Lessons for treatment monitoring and pre-transmission assessment surveys
2025PLoS neglected tropical diseasesJournalOpen access3 citations10.1371/journal.pntd.0012802
Humoral immune response to COVID-19 vaccines in onchocerciasis-infected individuals: a field study from Ghana
2025Frontiers in ImmunologyJournalOpen access0 citations10.3389/fimmu.2025.1633187
Efficacy of Intensified Hygiene Measures with or without the Addition of Doxycycline in the Management of Filarial Lymphedema: A Randomized Double-Blind, Placebo-Controlled Clinical Trial in Tanzania
2024American Journal of Tropical Medicine and HygieneJournalOpen accessCorresponding6 citations10.4269/ajtmh.24-0049
Adherence to Hygiene Protocols and Doxycycline Therapy in Ameliorating Lymphatic Filariasis Morbidity in an Endemic Area Post-Interruption of Disease Transmission in Ghana
2024American Journal of Tropical Medicine and HygieneJournalOpen access5 citations10.4269/ajtmh.24-0313
Stage-Dependent Increase of Systemic Immune Activation and CCR5+CD4+ T Cells in Filarial Driven Lymphedema in Ghana and Tanzania
2023PathogensJournalOpen access6 citations10.3390/pathogens12060809
Histopathological evaluation of Onchocerca volvulus nodules by microscopy and by digital image analysis for the study of macrofilaricidal drug efficacy
2023Frontiers in MedicineJournalOpen accessSenior authorCorresponding3 citations10.3389/fmed.2023.1099926
Filariasis research – from basic research to drug development and novel diagnostics, over a decade of research at the Institute for Medical Microbiology, Immunology and Parasitology, Bonn, Germany
2023Frontiers in Tropical DiseasesJournalOpen access7 citations10.3389/fitd.2023.1126173
Occurrence of Lymphatic Filariasis infection after 15 years of mass drug administration in two hotspot districts in the Upper East Region of Ghana
2022PLoS neglected tropical diseasesJournalOpen access19 citations10.1371/journal.pntd.0010129
The viability of utilising phone-based text messages in data capture and reporting morbidities due to lymphatic Filariasis by community health workers: a qualitative study in Kilwa district, Tanzania
2022BMC Health Services ResearchJournalOpen access5 citations10.1186/s12913-022-08256-z
A qPCR to quantify Wolbachia from few Onchocerca volvulus microfilariae as a surrogate for adult worm histology in clinical trials of antiwolbachial drugs
2022Parasitology ResearchJournalOpen access3 citations10.1007/s00436-021-07411-5